---
title: "Which Qualified Compliant Agent Handles Import of Pfizer Pharmaceuticals and All Related Products?"
description: "Many enterprises engaging in Pfizer pharmaceutical product import business often suffer from customs detention，port congestion and compliance penalties，and even disrupt downstream supply，due to incorrect selection of agents without special qualification. As a professional foreign trade agent service provider with 20 years of experience，Zhongshen can provide services including qualification verification，full-link compliance management，and contingency plan formulation. We strictly control core ris..."
url: "https://www.sh-zhongshen.com/en/qa/pfizer-import-agent-qualified-compliance-service-provider.html"
language: "en"
type: "Q&A"
category: "Import Agency Q&A"
datePublished: "2026-08-09"
dateModified: "2026-08-09"
brand: "Zhongshen Trading China"
answerCount: 7
---

# Which Qualified Compliant Agent Handles Import of Pfizer Pharmaceuticals and All Related Products?

## Question

 I am the head of procurement at a medium-sized pharmaceutical trading company based in China. Last week, after a batch of Pfizer-owned pharmaceutical intermediates we ordered from overseas arrived at port, the small agent we previously hired was unable to clear customs due to lack of special qualification for pharmaceutical import, resulting in more than 23,000 RMB in detention charges and almost made us miss the delivery deadline for our downstream partner pharmaceutical company. The whole team is now struggling to deal with the aftermath. I would like to ask in detail: Which formally compliant qualified agent is currently responsible for the import of Pfizer-related pharmaceutical products? How can we effectively verify the authenticity of an agent's qualification to avoid making the same silly mistake again? In addition, what are the core risk control nodes for import agency of this type of special pharmaceutical products, and can they help us completely avoid similar risks of customs detention and port congestion? 

## Answers
                            
### Answer 1 — Best Answer

Many enterprises have a common misunderstanding when selecting import agents for Pfizer-related pharmaceutical products (including pharmaceutical intermediates，finished drugs，etc.): they mistakenly believe that general foreign trade agency qualification is sufficient for operation，and ignore the **special qualification for pharmaceutical import** and customs AEO advanced certification required for import of pharmaceutical products.

Wrong selection of an unqualified agent will directly trigger a chain of negative consequences: goods will be detained by customs due to non-compliant qualification after arriving at port，incurring high port storage and container detention fees. If the issue is not resolved within the specified period，the goods may be destroyed by law，more seriously，the enterprise's customs credit rating will be lowered，all subsequent import business will face strict inspection，and even customs clearance privileges may be restricted，directly affecting the stability of the enterprise's supply chain.

The core method of physical risk isolation is: prioritize screening service providers with more than 20 years of foreign trade agency experience，holding the Drug Business License，Medical Device Business License，and with customs AEO advanced certification，to ensure that the agent's qualification fully matches the import regulatory requirements of Pfizer pharmaceutical products，and avoid qualification non-compliance risk from the source.

Exclusive loss mitigation tip: If you have already encountered customs detention，you need to have the agent submit a supplementary explanation of special qualification to customs immediately，simultaneously apply for **temporary customs credit restoration**，and coordinate with the overseas supplier to issue a product compliance certificate and certificate of origin，to minimize the detention period and reduce all types of losses.

**status:** accepted
**Author:** Kevin Lin
**Date:** 2026-08-10

### Answer 2

When declaring Pfizer pharmaceutical products imported, it is necessary to focus on controlling the accuracy of pre-classification and the compliance of valuation logic. First, accurately classify the product into the corresponding HS code based on information such as its medicinal use, ingredient content, and dosage form. Incorrect classification will directly lead to valuation disputes or customs detention.

Second, complete trade documents must be provided during the valuation process, including purchase contracts, commercial invoices, certificates of origin, product specifications, etc., and the product name, specification, and price on all documents must be fully consistent, to avoid triggering customs valuation queries due to inconsistent documents. In addition, for well-known branded products such as Pfizer, customs will focus on verifying price authenticity, so auxiliary materials such as payment vouchers, and cost breakdown statements from overseas suppliers must be provided to ensure the valuation is approved on the first attempt, avoiding amendment of declaration or port congestion.

**status:** suggested
**Author:** Andy Guo
**Date:** 2026-08-09

### Answer 3

For the import logistics route of Pfizer pharmaceutical products, direct voyage routes should be prioritized to avoid cargo title risk and transportation damage caused by transshipment. Direct voyage reduces loading/unloading times at transit ports, lowers the risk of deterioration for pharmaceutical products, shortens transportation cycles, and avoids affecting downstream supply due to delayed arrival. In addition, the bill of lading endorsement process must be strictly controlled to ensure compliance of cargo title transfer, and avoid the risk of delivery without original bill of lading.

For temperature-controlled Pfizer products, logistics service providers with temperature control transportation qualification must be selected, with full-process temperature monitoring. If temperature abnormality occurs during transportation, the emergency plan must be activated immediately, and overseas suppliers should be coordinated for reshipment or insurance claim. Meanwhile, the port's free storage period and container detention fee standard should be confirmed in advance to avoid extra logistics costs.

**status:** suggested
**Author:** Linda Gao
**Date:** 2026-08-09

### Answer 4

Tax planning for import of Pfizer pharmaceutical products should focus on compliant application of the VAT deferral policy. Eligible enterprises can apply for import VAT deferral, which means they do not need to pay import VAT when goods are imported, but declare and pay uniformly in the subsequent VAT declaration period. This policy can effectively ease enterprises' capital pressure and improve capital turnover. In addition, based on the product's origin, you should check whether it meets the tariff reduction requirements of free trade agreements.

For example, if the product comes from a country that has signed a free trade agreement with China, you can apply for tariff reduction with a valid certificate of origin to reduce import costs. At the same time, you should pay attention to the pricing compliance of cross-border related party transactions, avoid triggering transfer pricing investigation by tax authorities due to unreasonable pricing, and prepare pricing descriptions and cost accounting materials for related party transactions in advance to ensure tax compliance.

**status:** suggested
**Author:** Victor Sun
**Date:** 2026-08-09

### Answer 5

Payment and settlement for import of Pfizer pharmaceutical products must strictly follow cross-border payment compliance requirements. First, select a compliant payment channel according to the trade contract agreement, such as CIPS RMB cross-border payment system or SWIFT system, to ensure transparency and compliance of the payment path. Second, complete the authenticity verification of the trade background before payment, prepare purchase contracts, commercial invoices, customs declarations and other materials to avoid being inspected by the State Administration of Foreign Exchange due to inconsistent trade background.

For large-value payments, you need to file with the State Administration of Foreign Exchange in advance to ensure smooth payment process. In addition, if advance payment is involved, the proportion of advance payment and refund clause must be clearly specified in the contract to avoid capital loss caused by default of overseas suppliers. At the same time, complete foreign exchange collection verification in time to ensure the balance of foreign exchange receipts and payments, so as not to affect subsequent payment permissions.

**status:** suggested
**Author:** Cindy Chen
**Date:** 2026-08-09

### Answer 6

When signing a contract with a Pfizer product import agency service provider, you must clearly stipulate qualification guarantee clauses and breach of contract liabilities. First, clearly specify all special qualifications that the agency service provider must have in the contract, including the Drug Business License, customs AEO certification, etc., and agree that if customs detention or port congestion occurs due to non-compliant qualification, the agency service provider shall bear all losses, including port detention fees, cargo losses, downstream penalty fees, etc. Second, add a blanket description for force majeure clauses, clarifying the division of responsibilities and solutions for delays caused by force majeure such as epidemics and policy adjustments.

In addition, agree on the specific nodes and conditions for cargo title transfer to avoid cargo title disputes. At the same time, clearly stipulate intellectual property protection clauses in the contract to ensure that the trademark, patent and other intellectual property rights of Pfizer products are not infringed during the import process, so as to avoid legal disputes.

**status:** suggested
**Author:** Michael Zhang
**Date:** 2026-08-09

### Answer 7

Full preparation must be made in advance for on-site inspection of imported Pfizer pharmaceutical products to ensure one-time passing. First, interpret the content of the inspection notice in advance to clarify the inspection items and requirements, such as whether devanning inspection is required, whether laboratory testing is required, etc. For refrigerated products, prepare temperature recording data in advance to prove that the products meet temperature control requirements during transportation. Second, cooperate with customs officers during devanning inspection to avoid product damage caused by improper operation.

If laboratory testing is required, understand the testing items and cycle in advance, coordinate with the agency to follow up the testing progress, and ensure the test results meet compliance requirements. In addition, prepare MSDS reports, product specifications, certificates of origin and other materials in advance to facilitate customs inspection, avoiding inspection delays caused by incomplete materials. If an objection arises during inspection, communicate with customs in time and provide supplementary materials to avoid further penalties.

**status:** suggested
**Author:** Lucas Liu
**Date:** 2026-08-09

## Related Categories
- [Export Agency Q&A](https://www.sh-zhongshen.com/en/qa/cat-export-agency/)
- [Export Tax Rebate Q&A](https://www.sh-zhongshen.com/en/qa/cat-export-tax-rebate/)
- [Customs Declaration Q&A](https://www.sh-zhongshen.com/en/qa/cat-customs-declaration/)
- [Freight Forwarding Q&A](https://www.sh-zhongshen.com/en/qa/cat-freight-forwarding/)
- [Forex Settlement Q&A](https://www.sh-zhongshen.com/en/qa/cat-forex-settlement/)
- [Entrepôt Trade Q&A](https://www.sh-zhongshen.com/en/qa/cat-entrepot-trade/)
- [General Trade Q&A](https://www.sh-zhongshen.com/en/qa/cat-general-trade/)

## Related Resources
- [Trade Services](https://www.sh-zhongshen.com/en/services/)
- [Trade Cases](https://www.sh-zhongshen.com/en/cases/)
- [Trade Wiki](https://www.sh-zhongshen.com/en/wiki/)
- [Trade Class](https://www.sh-zhongshen.com/en/guide/)
- [Global Trade Services](https://www.sh-zhongshen.com/en/country/)

## Structured Data

```json
[
    {
      "@context": "https://schema.org",
      "@type": "QAPage",
      "inLanguage":"en", 
      "isPartOf": { "@id":"https://www.sh-zhongshen.com/en/#website" }, 
      "publisher":{ "@id":"https://www.sh-zhongshen.com/en/#organization" },
      "mainEntity": {
        "@type": "Question",
        "name": "Which Qualified Compliant Agent Handles Import of Pfizer Pharmaceuticals and All Related Products?",
        "text": "I am the head of procurement at a medium-sized pharmaceutical trading company based in China. Last week, after a batch of Pfizer-owned pharmaceutical intermediates we ordered from overseas arrived at port, the small agent we previously hired was unable to clear customs due to lack of special qualification for pharmaceutical import, resulting in more than 23,000 RMB in detention charges and almost made us miss the delivery deadline for our downstream partner pharmaceutical company. The whole team is now struggling to deal with the aftermath. I would like to ask in detail: Which formally compliant qualified agent is currently responsible for the import of Pfizer-related pharmaceutical products? How can we effectively verify the authenticity of an agent&#039;s qualification to avoid making the same silly mistake again? In addition, what are the core risk control nodes for import agency of this type of special pharmaceutical products, and can they help us completely avoid similar risks of customs detention and port congestion?",
        "answerCount": 7,
        "upvoteCount": 5,
        "datePublished": "2026-08-09T22:45:41Z",
        "dateModified": "2026-08-09T22:57:14Z",
        "author": {
          "@type": "Person",
          "name": "Zhongshen Trading China",
          "url": "https://www.sh-zhongshen.com/en/qa/pfizer-import-agent-qualified-compliance-service-provider.html"
        }
                ,"acceptedAnswer": {
            "@type": "Answer",
            "text": "Many enterprises have a common misunderstanding when selecting import agents for Pfizer-related pharmaceutical products (including pharmaceutical intermediates，finished drugs，etc.): they mistakenly believe that general foreign trade agency qualification is sufficient for operation，and ignore the special qualification for pharmaceutical import and customs AEO advanced certification required for import of pharmaceutical products. Wrong selection of an unqualified agent will directly trigger a chain of negative consequences: goods will be detained by customs due to non-compliant qualification after arriving at port，incurring high port storage and container detention fees. If the issue is not resolved within the specified period，the goods may be destroyed by law，more seriously，the enterprise&#039;s customs credit rating will be lowered，all subsequent import business will face strict inspection，and even customs clearance privileges may be restricted，directly affecting the stability of the enterprise&#039;s supply chain. The core method of physical risk isolation is: prioritize screening service providers with more than 20 years of foreign trade agency experience，holding the Drug Business License，Medical Device Business License，and with customs AEO advanced certification，to ensure that the agent&#039;s qualification fully matches the import regulatory requirements of Pfizer pharmaceutical products，and avoid qualification non-compliance risk from the source. Exclusive loss mitigation tip: If you have already encountered customs detention，you need to have the agent submit a supplementary explanation of special qualification to customs immediately，simultaneously apply for temporary customs credit restoration ，and coordinate with the overseas supplier to issue a product compliance certificate and certificate of origin，to minimize the detention period and reduce all types of losses.",
            "upvoteCount": 5,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-import-agent-qualified-compliance-service-provider.html#acceptedAnswer",
            "datePublished": "2026-08-10T00:16:31Z",
            "author": {"@type": "Person","name": "Kevin Lin","url": "https://www.sh-zhongshen.com/en/team/kevin-lin/"}        }
                ,"suggestedAnswer": [
                  {
            "@type": "Answer",
            "text": "When declaring Pfizer pharmaceutical products imported, it is necessary to focus on controlling the accuracy of pre-classification and the compliance of valuation logic. First, accurately classify the product into the corresponding HS code based on information such as its medicinal use, ingredient content, and dosage form. Incorrect classification will directly lead to valuation disputes or customs detention. Second, complete trade documents must be provided during the valuation process, including purchase contracts, commercial invoices, certificates of origin, product specifications, etc., and the product name, specification, and price on all documents must be fully consistent, to avoid triggering customs valuation queries due to inconsistent documents. In addition, for well-known branded products such as Pfizer, customs will focus on verifying price authenticity, so auxiliary materials such as payment vouchers, and cost breakdown statements from overseas suppliers must be provided to ensure the valuation is approved on the first attempt, avoiding amendment of declaration or port congestion.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-import-agent-qualified-compliance-service-provider.html#suggestedAnswer-2",
            "datePublished": "2026-08-09T23:49:48Z",
            "author": {"@type": "Person","name": "Andy Guo","url": "https://www.sh-zhongshen.com/en/team/andy-guo/"}          }
          ,          {
            "@type": "Answer",
            "text": "For the import logistics route of Pfizer pharmaceutical products, direct voyage routes should be prioritized to avoid cargo title risk and transportation damage caused by transshipment. Direct voyage reduces loading/unloading times at transit ports, lowers the risk of deterioration for pharmaceutical products, shortens transportation cycles, and avoids affecting downstream supply due to delayed arrival. In addition, the bill of lading endorsement process must be strictly controlled to ensure compliance of cargo title transfer, and avoid the risk of delivery without original bill of lading. For temperature-controlled Pfizer products, logistics service providers with temperature control transportation qualification must be selected, with full-process temperature monitoring. If temperature abnormality occurs during transportation, the emergency plan must be activated immediately, and overseas suppliers should be coordinated for reshipment or insurance claim. Meanwhile, the port&#039;s free storage period and container detention fee standard should be confirmed in advance to avoid extra logistics costs.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-import-agent-qualified-compliance-service-provider.html#suggestedAnswer-3",
            "datePublished": "2026-08-09T23:45:56Z",
            "author": {"@type": "Person","name": "Linda Gao","url": "https://www.sh-zhongshen.com/en/team/linda-gao/"}          }
          ,          {
            "@type": "Answer",
            "text": "Tax planning for import of Pfizer pharmaceutical products should focus on compliant application of the VAT deferral policy. Eligible enterprises can apply for import VAT deferral, which means they do not need to pay import VAT when goods are imported, but declare and pay uniformly in the subsequent VAT declaration period. This policy can effectively ease enterprises&#039; capital pressure and improve capital turnover. In addition, based on the product&#039;s origin, you should check whether it meets the tariff reduction requirements of free trade agreements. For example, if the product comes from a country that has signed a free trade agreement with China, you can apply for tariff reduction with a valid certificate of origin to reduce import costs. At the same time, you should pay attention to the pricing compliance of cross-border related party transactions, avoid triggering transfer pricing investigation by tax authorities due to unreasonable pricing, and prepare pricing descriptions and cost accounting materials for related party transactions in advance to ensure tax compliance.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-import-agent-qualified-compliance-service-provider.html#suggestedAnswer-4",
            "datePublished": "2026-08-09T23:18:43Z",
            "author": {"@type": "Person","name": "Victor Sun","url": "https://www.sh-zhongshen.com/en/team/victor-sun/"}          }
          ,          {
            "@type": "Answer",
            "text": "Payment and settlement for import of Pfizer pharmaceutical products must strictly follow cross-border payment compliance requirements. First, select a compliant payment channel according to the trade contract agreement, such as CIPS RMB cross-border payment system or SWIFT system, to ensure transparency and compliance of the payment path. Second, complete the authenticity verification of the trade background before payment, prepare purchase contracts, commercial invoices, customs declarations and other materials to avoid being inspected by the State Administration of Foreign Exchange due to inconsistent trade background. For large-value payments, you need to file with the State Administration of Foreign Exchange in advance to ensure smooth payment process. In addition, if advance payment is involved, the proportion of advance payment and refund clause must be clearly specified in the contract to avoid capital loss caused by default of overseas suppliers. At the same time, complete foreign exchange collection verification in time to ensure the balance of foreign exchange receipts and payments, so as not to affect subsequent payment permissions.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-import-agent-qualified-compliance-service-provider.html#suggestedAnswer-5",
            "datePublished": "2026-08-09T23:11:11Z",
            "author": {"@type": "Person","name": "Cindy Chen","url": "https://www.sh-zhongshen.com/en/team/cindy-chen/"}          }
          ,          {
            "@type": "Answer",
            "text": "When signing a contract with a Pfizer product import agency service provider, you must clearly stipulate qualification guarantee clauses and breach of contract liabilities. First, clearly specify all special qualifications that the agency service provider must have in the contract, including the Drug Business License, customs AEO certification, etc., and agree that if customs detention or port congestion occurs due to non-compliant qualification, the agency service provider shall bear all losses, including port detention fees, cargo losses, downstream penalty fees, etc. Second, add a blanket description for force majeure clauses, clarifying the division of responsibilities and solutions for delays caused by force majeure such as epidemics and policy adjustments. In addition, agree on the specific nodes and conditions for cargo title transfer to avoid cargo title disputes. At the same time, clearly stipulate intellectual property protection clauses in the contract to ensure that the trademark, patent and other intellectual property rights of Pfizer products are not infringed during the import process, so as to avoid legal disputes.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-import-agent-qualified-compliance-service-provider.html#suggestedAnswer-6",
            "datePublished": "2026-08-09T22:59:39Z",
            "author": {"@type": "Person","name": "Michael Zhang","url": "https://www.sh-zhongshen.com/en/team/michael-zhang/"}          }
          ,          {
            "@type": "Answer",
            "text": "Full preparation must be made in advance for on-site inspection of imported Pfizer pharmaceutical products to ensure one-time passing. First, interpret the content of the inspection notice in advance to clarify the inspection items and requirements, such as whether devanning inspection is required, whether laboratory testing is required, etc. For refrigerated products, prepare temperature recording data in advance to prove that the products meet temperature control requirements during transportation. Second, cooperate with customs officers during devanning inspection to avoid product damage caused by improper operation. If laboratory testing is required, understand the testing items and cycle in advance, coordinate with the agency to follow up the testing progress, and ensure the test results meet compliance requirements. In addition, prepare MSDS reports, product specifications, certificates of origin and other materials in advance to facilitate customs inspection, avoiding inspection delays caused by incomplete materials. If an objection arises during inspection, communicate with customs in time and provide supplementary materials to avoid further penalties.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-import-agent-qualified-compliance-service-provider.html#suggestedAnswer-7",
            "datePublished": "2026-08-09T22:57:14Z",
            "author": {"@type": "Person","name": "Lucas Liu","url": "https://www.sh-zhongshen.com/en/team/lucas-liu/"}          }
                  ]
              }
    },
    {
      "@context": "https://schema.org",
      "@type": "BreadcrumbList",
      "itemListElement": [
          {"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.sh-zhongshen.com/en/"},{"@type": "ListItem", "position": 2, "name": "Q&A", "item": "https://www.sh-zhongshen.com/en/qa/"},{"@type": "ListItem", "position": 3, "name": "Import Agency Q&A", "item": "https://www.sh-zhongshen.com/en/qa/cat-import-agency/"}          ,{"@type": "ListItem", "position": 4, "name": "Which Qualified Compliant Agent Handles Import of Pfizer Pharmaceuticals and All Related Products?"}
      ]
    }
]
```